Inhalation of molecular hydrogen prevents ischemia-reperfusion liver damage during major liver resection.
Malý O, Zajak J, Hyšpler R, Turek Z, Astapenko D, Jun D, Váňová N, Kohout A, Radochová V, Kotek J, Páral J · Annals of translational medicine · 2019
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Inhalation of molecular hydrogen prevents ischemia-reperfusion liver damage during major liver resection.” is organized in H2HUBB under the research focus hydrogen inhalation fatty liver study 2019. The publication is cited as Malý O, Zajak J, Hyšpler R, Turek Z, Astapenko D, Jun D, Váňová N, Kohout A, Radochová V, Kotek J, Páral J, Annals of translational medicine, 2019. This animal study examined Inhalation of molecular hydrogen prevents ischemia-reperfusion liver damage during major liver resection. The abstract describes Porcine model; hydrogen delivered as hydrogen inhalation; reported duration 120 minutes. The abstract reports: In this experimental study, we showed that inhaled hydrogen during major liver resection unquestionably reduced the level of oxidative stress associated with ischemia-reperfusion damage.…. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen inhalation fatty liver study 2019 overview
Liver resection is a surgical procedure associated with a high risk of hepatic failure that can be fatal. One of the key mechanisms involves… Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.
Study design and hydrogen intervention
Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Porcine model. Blinding: Unknown. Control status: Control group reported.
Delivery method: Hydrogen inhalation. Treatment duration: 120 minutes.
Reported findings and scientific interpretation
For this hydrogen inhalation fatty liver study 2019, the study record reports the following: The abstract reports: In this experimental study, we showed that inhaled hydrogen during major liver resection unquestionably reduced the level of oxidative stress associated with ischemia-reperfusion damage.…
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Preclinical animal findings may not translate directly to human outcomes.
The intervention or follow-up period appears relatively short.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.